FDA Approves Natalizumab For Sandoz And Polpharma Biologics

Tyruko Biosimilar Rival To Tysabri Approved In US Following Recent European Nod

US flag thumbs up
Tyruko has now been approved in the US • Source: Shutterstock

More from Products

More from Generics Bulletin